ONO 1603;N-[(4-chlorophenyl)methyl]-4-[(2S)-2-formylpyrrolidin-1-yl]-4-oxobutanamide;1-Pyrrolidinebutanamide, N-[(4-chlorophenyl)methyl]-2-formyl-γ-oxo-, (2S)-
ONO1603 is a prolyl endopeptidase (PREP) inhibitor and anti-dementia agent; it exhibits neuroprotective and neurotrophic effects similar to tacrine (THA) in cerebellar granule cells; at a concentration of 0.03 μM, it promotes neuronal survival, enhances neurite outgrowth, upregulates M3 muscarinic acetylcholine receptor (mAChR) mRNA levels, and stimulates mAChR-mediated signaling pathways; it has potential as a therapeutic agent for Alzheimer's disease by enhancing cholinergic neurotransmission and neuronal function.